Parkinsonism & related disorders · 2013
Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sundal Christina, Fujioka Shinsuke, Van Gerpen Jay A, Wider Christian, Nicholson Alexandra M, Baker Matt, Shuster Elizabeth A, Aasly Jan, Spina Salvatore, Ghetti Bernardino, Roeber Sigrun, Garbern James, Tselis Alex, Swerdlow Russell H, Miller Bradley B, Borjesson-Hanson Anne, Uitti Ryan J, Ross Owen A, Stoessl A Jon, Rademakers Rosa, Josephs Keith A, Dickson Dennis W, Broderick Daniel, Wszolek Zbigniew K
Аннотация
Atypical Parkinsonism associated with white matter pathology has been described in cerebrovascular diseases, mitochondrial cytopathies, osmotic demyelinating disorders, leukoencephalopathies leukodystrophies, and others. Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an autosomal dominant disorder with symptomatic onset in midlife and death within a few years after symptom onset. Neuroimaging reveals cerebral white matter lesions that are pathologically characterized by non-inflammatory myelin loss, reactive astrocytosis, and axonal spheroids. Most cases are caused by mutations in the colony-stimulating factor 1 receptor (CSF1R) gene. We studied neuropathologically verified HDLS patients with CSF1R mutations to assess parkinsonian features. Ten families were evaluated with 16 affected individuals. During the course of the illness, all patients had at least some degree of bradykinesia. Fifteen patients had postural instability, and seven had rigidity. Two patients initially presented with parkinsonian gait and asymmetrical bradykinesia. These two patients and two others exhibited bradykinesia, rigidity, postural instability, and tremor (two with resting) early in the course of the illness. Levodopa/carbidopa therapy in these four patients provided no benefit, and the remaining 12 patients were not treated. The mean age of onset for all patients was about 45 years (range, 18-71) and the mean disease duration was approximately six years (range, 3-11). We also reviewed HDLS patients published prior to the CSF1R discovery for the presence of parkinsonian features. Out of 50 patients, 37 had gait impairments, 8 rigidity, 7 bradykinesia, and 5 resting tremor. Our report emphasizes the presence of atypical Parkinsonism in HDLS due to CSF1R mutations.
Предметные рубрики MeSH
AdolescentAdultAge of OnsetAgedAntiparkinson AgentsBiological Specimen BanksBrainFamilyFemaleGait Disorders, NeurologicGliosisHumansHypokinesiaImage Processing, Computer-AssistedLeukoencephalopathiesMagnetic Resonance ImagingMaleMiddle AgedMuscle RigidityMutationNeuroimagingParkinson DiseaseReceptor, Macrophage Colony-Stimulating FactorTremorUnited KingdomYoung Adult